Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gils

Showing results (51-60 of 58) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 58 results.
Alimentary Pharmacology & Therapeutics|December 12, 2017
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical responseE Dreesen, T Van Stappen, V Ballet, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2012
Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' replyD J Buurman, N Vande Casteele, M G G Sturkenboom, et al.
Alimentary Pharmacology & Therapeutics|September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseasesK Papamichael, T Van Stappen, V Jairath, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2017
Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in miceC Tersteeg, B S Joly, A Gils, et al.
Obesity Surgery|August 16, 2018
Effects of Two Preoperatory Weight Loss Diets on Hepatic Volume, Metabolic Parameters, and Surgical Complications in Morbid Obese Bariatric Surgery Candidates: a Randomized Clinical TrialA Gils Contreras, A Bonada Sanjaume, M Montero Jaime, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in childrenM Emonts, E L E de Bruijne, A H C Guimarães, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumabH Peeters, E Louis, F Baert, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2009
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC studyE L E de Bruijne, A Gils, A H C Guimarães, et al.
Pageof 6

Showing results (51-60 of 58) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 58 results.
Alimentary Pharmacology & Therapeutics|December 12, 2017
Anti-infliximab antibody concentrations can guide treatment intensification in patients with Crohn's disease who lose clinical responseE Dreesen, T Van Stappen, V Ballet, et al.
Alimentary Pharmacology & Therapeutics|December 21, 2012
Letter: detection of infliximab levels and anti-infliximab antibodies--comparison of three different assays; authors' replyD J Buurman, N Vande Casteele, M G G Sturkenboom, et al.
Alimentary Pharmacology & Therapeutics|September 15, 2015
Review article: pharmacological aspects of anti-TNF biosimilars in inflammatory bowel diseasesK Papamichael, T Van Stappen, V Jairath, et al.
Journal of Thrombosis and Haemostasis : JTH|October 6, 2017
Amplified endogenous plasmin activity resolves acute thrombotic thrombocytopenic purpura in miceC Tersteeg, B S Joly, A Gils, et al.
Obesity Surgery|August 16, 2018
Effects of Two Preoperatory Weight Loss Diets on Hepatic Volume, Metabolic Parameters, and Surgical Complications in Morbid Obese Bariatric Surgery Candidates: a Randomized Clinical TrialA Gils Contreras, A Bonada Sanjaume, M Montero Jaime, et al.
Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in childrenM Emonts, E L E de Bruijne, A H C Guimarães, et al.
Acta Gastro-Enterologica Belgica|March 22, 2018
Efficacy of switching to infliximab in patients with Crohn's disease with loss of response to adalimumabH Peeters, E Louis, F Baert, et al.
Journal of Thrombosis and Haemostasis : JTH|March 28, 2009
The role of thrombin activatable fibrinolysis inhibitor in arterial thrombosis at a young age: the ATTAC studyE L E de Bruijne, A Gils, A H C Guimarães, et al.
Pageof 6